Gsk Plc ADR (GSK-N) Analyst Research & Price Targets - The Globe and Mail

Add to Watchlist Create Alerts

Real-Time Last Update

Last Sale Cboe BZX Real-Time

Volume

Current Target Price

High Target Price

Mean Target Price

Low Target Price

Median Target Price

Earnings Estimates

	Current Qtr03/2024	Next Qtr06/2024	Fiscal Yr12/2024	Fiscal Yr12/2025
Average Estimate	0.94	1.03	4.03	4.43
Number of Estimates	4	2	7	6
High Estimate	1.03	1.10	4.25	4.58
Low Estimate	0.90	0.96	3.91	4.32
Prior Year	0.90	0.97	3.86	4.03
Growth Rate Est. (year over year)	+4.44%	+6.19%	+4.40%	+9.93%

Earnings History - Surprises*

	Qtr Ending12/2023	Qtr Ending09/2023	Qtr Ending06/2023	Qtr Ending03/2023
Reported	$0.72	$1.26	$0.97	$0.90
Estimate	$0.76	$1.09	$0.85	$0.85
Difference	-0.04	+0.17	+0.12	+0.05
Surprise	-5.26%	+15.60%	+14.12%	+5.88%

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

2.63

3 Mths Ago8

2.88

2 Mths Ago8

3.11

1 Mth Ago9

3.11

Current9

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	8	8	9	9
	1	2	3	3
Holds	4	3	3	3
	1 2	1 2	1 2	1 2

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

The close: Stocks higher as investors focus on Fed moves

The close: Major North American indexes rise as megacap tech stocks rally

Why this money manager is venturing back into emerging markets and adding more U.S. tech

How a Canadian pirate-clad pastor helped ignite Trump Media’s market frenzy

Activist investor targets Dye & Durham’s ‘underperformance and strategic missteps’ in letter to shareholders

The close: U.S. stocks fall as GDP report spreads rate-cut gloom; Alphabet surges 15% in post market

Fiera Capital’s largest shareholder looks to sell stake in company

The close: S&P 500 higher as markets weigh rising bond yields and upbeat U.S. earnings; TSX lower as rails slide